menu close
www.adimab.com

Adimab Stock

Company Profile:

Adimab operates as an antibody discovery company. Adimab selects high affinity antibodies that behave well in a formulation and manufacturing context. Adimab selects human antibodies with its formulation and manufacturing characteristics by integrating all aspects of antibody discovery and developing screening methods.

Sign up for SecondMarket™ to view the market and buy or sell Adimab Stock
Buy + Sell
Leverage Your Equity to Help Achieve More.

Adimab Management Team

  • Director

    Mike Ross

  • Director

    Bill Maris

  • Director

    Terry McGuire

  • COO, Director

    Errik B. Anderson

  • CEO, Director

    Tillman U. Gerngross

Adimab Major Investors

  • OrbiMed Advisors LLC

  • Google Ventures (GV)

  • Polaris Partners

  • SV Life Sciences Advisers LLC

  • Borealis Ventures

Learn More About Adimab Stock

Buy Adimab Stock
01

Adimab stock does not trade on public stock exchanges. Adimab stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Adimab stock you can either buy shares directly through company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Adimab Stock
02

Adimab Stock does not trade on public stock exchanges. In order to sell Adimab shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Adimab Stock Price
03

Adimab does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Adimab share price and other valuable private market data.

Read more about secondary market private company stock prices:

Adimab Stock Ticker Symbol
04

There is no ticker symbol for Adimab stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Adimab Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Adimab stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Adimab Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Adimab stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Adimab Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Adimab IPO
08

Adimab is a private company and has not had an IPO. There is currently no Adimab IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Adimab IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket™ to view the market and buy or sell Adimab Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Insitro-Logo

insitro

Drug discovery and development company.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

A new biopharmaceutical company using revolutionary technology to discover novel treatments for life-threatening diseases.

Indigoag-Logo

Indigo Agriculture

Improves grower profitability, environmental sustainability, and consumer health through the use of natural microbiology and digital technologies.

Weareresilience-Logo

Resilience

Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Geltor

Animal-free, category-defining ingredients.

Click Therapeutics

Biotechnology company that develops, validates, and commercializes software as prescription medical treatments

Dren Bio

Developing powerful protein engineering technologies to deplete cells, protein aggregates and other disease-causing agents.

Source: Nasdaq Private Market Tape D™